HEADER TRANSFERASE 02-FEB-11 3QLG TITLE CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE TITLE 2 DOMAIN COMPLEXED WITH DASATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTO-ONCOGENE C-SRC, PP60C-SRC, P60-SRC; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: BANTAM,CHICKENS; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A+ KEYWDS C-SRC L317I MUTANT, TYROSINE KINASE, TRANSFERASE, DASATINIB EXPDTA X-RAY DIFFRACTION AUTHOR R.BOUBEVA,L.PERNOT,R.PEROZZO,L.SCAPOZZA REVDAT 2 13-SEP-23 3QLG 1 REMARK SEQADV REVDAT 1 08-FEB-12 3QLG 0 JRNL AUTH R.BOUBEVA,L.PERNOT,A.CRISTIANI,L.MORETTI,A.BERTEOTTI, JRNL AUTH 2 R.PEROZZO,F.GERVASIO,L.SCAPOZZA JRNL TITL A SINGLE AMINO-ACID DICTATES THE DYNAMICS OF THE SWITCH JRNL TITL 2 BETWEEN ACTIVE AND INACTIVE C-SRC CONFORMATION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.SEELIGER,B.NAGAR,F.FRANK,X.CAO,M.N.HENDERSON,J.KURIYAN REMARK 1 TITL C-SRC BINDS TO THE CANCER DRUG IMATINIB WITH AN INACTIVE REMARK 1 TITL 2 ABL/C-KIT CONFORMATION AND A DISTRIBUTED THERMODYNAMIC REMARK 1 TITL 3 PENALTY. REMARK 1 REF STRUCTURE V. 15 299 2007 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 17355866 REMARK 1 DOI 10.1016/J.STR.2007.01.015 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.C.DAR,M.S.LOPEZ,K.M.SHOKAT REMARK 1 TITL SMALL MOLECULE RECOGNITION OF C-SRC VIA THE IMATINIB-BINDING REMARK 1 TITL 2 CONFORMATION. REMARK 1 REF CHEM.BIOL. V. 15 1015 2008 REMARK 1 REFN ISSN 1074-5521 REMARK 1 PMID 18940662 REMARK 1 DOI 10.1016/J.CHEMBIOL.2008.09.007 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.2_432) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.070 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 18782 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 912 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.4788 - 5.2554 0.97 2634 101 0.2275 0.2653 REMARK 3 2 5.2554 - 4.1737 0.97 2571 146 0.1706 0.2538 REMARK 3 3 4.1737 - 3.6468 0.96 2606 146 0.1859 0.2688 REMARK 3 4 3.6468 - 3.3136 0.97 2561 134 0.1924 0.2608 REMARK 3 5 3.3136 - 3.0763 0.96 2593 146 0.1992 0.2760 REMARK 3 6 3.0763 - 2.8950 0.96 2559 128 0.2263 0.2951 REMARK 3 7 2.8950 - 2.7500 0.87 2346 111 0.2368 0.2889 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 43.73 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.76890 REMARK 3 B22 (A**2) : -12.67090 REMARK 3 B33 (A**2) : 8.90200 REMARK 3 B12 (A**2) : -0.63730 REMARK 3 B13 (A**2) : -3.19900 REMARK 3 B23 (A**2) : -4.58530 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4280 REMARK 3 ANGLE : 0.944 5816 REMARK 3 CHIRALITY : 0.059 620 REMARK 3 PLANARITY : 0.003 742 REMARK 3 DIHEDRAL : 14.896 1588 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QLG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063793. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18788 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 34.476 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.13400 REMARK 200 R SYM (I) : 0.09400 REMARK 200 FOR THE DATA SET : 12.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.48200 REMARK 200 R SYM FOR SHELL (I) : 0.34100 REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3OEZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7MG/ML PROTEIN, 0.25MM DASATINIB, 0.1M REMARK 280 MES, 0.2M SODIUM ACETATE, 4% GLYCEROL, 12% PEG 4000, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 LYS A 257 REMARK 465 LEU A 407 REMARK 465 ALA A 408 REMARK 465 ARG A 409 REMARK 465 LEU A 410 REMARK 465 ILE A 411 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 LEU B 297 REMARK 465 LYS B 298 REMARK 465 PRO B 299 REMARK 465 GLY B 300 REMARK 465 THR B 301 REMARK 465 ILE B 411 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 297 CG CD1 CD2 REMARK 470 LYS A 298 CD CE NZ REMARK 470 MET A 302 SD CE REMARK 470 GLN A 309 CG CD OE1 NE2 REMARK 470 GLN A 312 CG CD OE1 NE2 REMARK 470 LYS A 315 CG CD CE NZ REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 GLU A 353 CD OE1 OE2 REMARK 470 ARG A 438 CD NE CZ NH1 NH2 REMARK 470 ARG A 469 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 477 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 257 CG CD CE NZ REMARK 470 GLU B 261 OE2 REMARK 470 ARG B 268 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 272 CD CE NZ REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 GLN B 309 CG CD OE1 NE2 REMARK 470 GLU B 331 CG CD OE1 OE2 REMARK 470 GLU B 353 CG CD OE1 OE2 REMARK 470 LEU B 407 CG CD1 CD2 REMARK 470 ARG B 409 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 469 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 477 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 289 -45.69 -130.86 REMARK 500 ARG A 385 -19.25 92.28 REMARK 500 ASP A 386 43.11 -140.59 REMARK 500 ASP A 404 93.12 62.45 REMARK 500 GLN A 526 32.80 -88.25 REMARK 500 LYS B 257 150.04 -41.88 REMARK 500 ALA B 259 5.38 -60.74 REMARK 500 THR B 289 -20.29 -142.87 REMARK 500 ARG B 385 -19.49 92.27 REMARK 500 ASP B 404 96.64 55.67 REMARK 500 GLN B 526 33.46 -88.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OF0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE REMARK 900 KINASE DOMAIN REMARK 900 RELATED ID: 3OEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE REMARK 900 KINASE DOMAIN COMPLEXED WITH IMATINIB REMARK 900 RELATED ID: 3QLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE REMARK 900 DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE 5 REMARK 900 RELATED ID: 3G5D RELATED DB: PDB REMARK 900 KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB DBREF 3QLG A 251 533 UNP P00523 SRC_CHICK 251 533 DBREF 3QLG B 251 533 UNP P00523 SRC_CHICK 251 533 SEQADV 3QLG GLY A 248 UNP P00523 EXPRESSION TAG SEQADV 3QLG HIS A 249 UNP P00523 EXPRESSION TAG SEQADV 3QLG MET A 250 UNP P00523 EXPRESSION TAG SEQADV 3QLG ILE A 317 UNP P00523 LEU 317 ENGINEERED MUTATION SEQADV 3QLG GLY B 248 UNP P00523 EXPRESSION TAG SEQADV 3QLG HIS B 249 UNP P00523 EXPRESSION TAG SEQADV 3QLG MET B 250 UNP P00523 EXPRESSION TAG SEQADV 3QLG ILE B 317 UNP P00523 LEU 317 ENGINEERED MUTATION SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS ILE ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 A 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL MET LYS LYS ILE ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 B 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET 1N1 A 601 41 HET 1N1 B 601 41 HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETSYN 1N1 DASATINIB FORMUL 3 1N1 2(C22 H26 CL N7 O2 S) FORMUL 5 HOH *180(H2 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 SER A 303 LYS A 316 1 14 HELIX 3 3 LEU A 346 GLY A 352 1 7 HELIX 4 4 MET A 354 LEU A 358 5 5 HELIX 5 5 ARG A 359 MET A 380 1 22 HELIX 6 6 ARG A 388 ALA A 390 5 3 HELIX 7 7 PRO A 425 THR A 429 5 5 HELIX 8 8 ALA A 430 GLY A 437 1 8 HELIX 9 9 THR A 440 THR A 457 1 18 HELIX 10 10 VAL A 467 ARG A 477 1 11 HELIX 11 11 PRO A 488 TRP A 499 1 12 HELIX 12 12 THR A 508 ASP A 518 1 11 HELIX 13 13 ASP A 518 THR A 523 1 6 HELIX 14 14 PRO B 263 GLU B 265 5 3 HELIX 15 15 SER B 303 LYS B 316 1 14 HELIX 16 16 LEU B 346 GLY B 352 1 7 HELIX 17 17 MET B 354 LEU B 358 5 5 HELIX 18 18 ARG B 359 MET B 380 1 22 HELIX 19 19 ARG B 388 ALA B 390 5 3 HELIX 20 20 PRO B 425 THR B 429 5 5 HELIX 21 21 ALA B 430 GLY B 437 1 8 HELIX 22 22 THR B 440 THR B 457 1 18 HELIX 23 23 VAL B 467 ARG B 477 1 11 HELIX 24 24 PRO B 488 TRP B 499 1 12 HELIX 25 25 THR B 508 ASP B 518 1 11 HELIX 26 26 ASP B 518 THR B 523 1 6 SHEET 1 A 5 LEU A 267 GLN A 275 0 SHEET 2 A 5 GLY A 279 TRP A 286 -1 O MET A 283 N VAL A 271 SHEET 3 A 5 THR A 290 LEU A 297 -1 O ILE A 294 N TRP A 282 SHEET 4 A 5 TYR A 335 GLU A 339 -1 O THR A 338 N ALA A 293 SHEET 5 A 5 LEU A 325 VAL A 329 -1 N TYR A 326 O VAL A 337 SHEET 1 B 3 GLY A 344 SER A 345 0 SHEET 2 B 3 ILE A 392 VAL A 394 -1 O VAL A 394 N GLY A 344 SHEET 3 B 3 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 C 5 LEU B 267 GLN B 275 0 SHEET 2 C 5 GLU B 280 TRP B 286 -1 O MET B 283 N VAL B 271 SHEET 3 C 5 THR B 290 LYS B 295 -1 O ILE B 294 N TRP B 282 SHEET 4 C 5 TYR B 335 THR B 338 -1 O THR B 338 N ALA B 293 SHEET 5 C 5 LEU B 325 VAL B 329 -1 N ALA B 327 O VAL B 337 SHEET 1 D 3 GLY B 344 SER B 345 0 SHEET 2 D 3 ILE B 392 VAL B 394 -1 O VAL B 394 N GLY B 344 SHEET 3 D 3 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 CISPEP 1 GLU A 332 PRO A 333 0 -5.71 CISPEP 2 GLU B 332 PRO B 333 0 -4.75 SITE 1 AC1 11 LEU A 273 ALA A 293 LYS A 295 GLU A 310 SITE 2 AC1 11 THR A 338 GLU A 339 TYR A 340 MET A 341 SITE 3 AC1 11 SER A 342 GLY A 344 LEU A 393 SITE 1 AC2 13 ALA B 293 LYS B 295 GLU B 310 MET B 314 SITE 2 AC2 13 VAL B 323 ILE B 336 THR B 338 GLU B 339 SITE 3 AC2 13 TYR B 340 MET B 341 SER B 342 LYS B 343 SITE 4 AC2 13 LEU B 393 CRYST1 42.261 63.494 74.445 100.74 90.18 90.00 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023662 0.000000 0.000076 0.00000 SCALE2 0.000000 0.015750 0.002987 0.00000 SCALE3 0.000000 0.000000 0.013672 0.00000